March 28, 2023
RegMed Investors’ (RMi) pre-open: the market and sector turmoil ain’t over
March 27, 2023
RegMed Investors’ (RMi) pre-open: no bad bank news will be good news as Q1/23 will come to a close this week
March 24, 2023
RegMed Investors’ (RMi) pre-open: good news, it’s Friday
March 23, 2023
RegMed Investors’ (RMi) pre-open: Bottom, bottom is it in sight?
March 22, 2023
RegMed Investors’ (RMi) pre-open: What’s on tap?
March 21, 2023
RegMed Investors’ (RMi) pre-open: what’s the range of price movements?
March 20, 2023
RegMed Investors’ (RMi) pre-open: still vulnerable and receptive to electronic trading nibbles and bites
March 17, 2023
RegMed Investors’ (RMi) pre-open: a quadruple-witching Friday
March 16, 2023
RegMed Investors’ (RMi) pre-open: will there be another Black Swan event for the cell and gene therapy sector and how soon versus when?
March 15, 2023
RegMed Investors’ (RMi) pre-open: money’s leaving share pricing due to inherent risks
March 14, 2023
RegMed Investors’ (RMi) pre-open: from the fear of the SVB scenario came
March 10, 2023
RegMed Investors’ (RMi) pre-open: probably more down but, almost ready to start buying bottoms
March 9, 2023
RegMed Investors’ (RMi) pre-open: sector extends the slide while oversold seek value recognition
March 8, 2023
RegMed Investors’ (RMi) pre-open: just when you thought
March 7, 2023
RegMed Investors’ (RMi) pre-open: waiting to hang on Jerome’s policy message
March 6, 2023
RegMed Investors’ (RMi) pre-open: buy on downslide, sell into the upswing
March 3, 2023
RegMed Investors’ (RMi) pre-open: a test of strength versus weakness
March 2, 2023
RegMed Investors’ (RMi) pre-open: sector swings back and forth although I basically remain picking short-term indications
March 1, 2023
RegMed Investors’ (RMi) pre-open: don’t walk when the direction signs are flashing
February 28, 2023
RegMed Investors’ (RMi) pre-open: peaking while seeking acquiescence or validation
February 22, 2023
RegMed Investors’ (RMi) pre-open: pick-up a few of the oversold while we wait again for Jerome’s minutes
February 21, 2023
RegMed Investors’ (RMi) pre-open: after a holiday and week of wupp’in
February 17, 2023
RegMed Investors’ (RMi) pre-open: sector earning’s season reporting begins as volatility continues
February 16, 2023
RegMed Investors’ (RMi) pre-open: does the cell/gene therapy sector have legs with a new consignment of economic data?
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors